Maple Capital Management Inc. Boosts Holdings in Colgate-Palmolive (NYSE:CL)

Maple Capital Management Inc. boosted its stake in Colgate-Palmolive (NYSE:CL) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 126,732 shares of the company’s stock after acquiring an additional 4,504 shares during the period. Maple Capital Management Inc.’s holdings in Colgate-Palmolive were worth $11,521,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Chicago Partners Investment Group LLC grew its position in shares of Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock worth $591,000 after acquiring an additional 943 shares during the last quarter. Peak Financial Advisors LLC acquired a new stake in Colgate-Palmolive during the 4th quarter worth $1,315,000. Gordian Advisors LLC purchased a new position in Colgate-Palmolive during the 3rd quarter worth $602,000. Carrera Capital Advisors increased its stake in Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after purchasing an additional 7,353 shares during the period. Finally, Fiduciary Alliance LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $4,066,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $91.27 on Friday. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The company has a market cap of $74.07 billion, a price-to-earnings ratio of 25.93, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. The stock’s 50-day moving average is $88.74 and its 200-day moving average is $95.51.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the company earned $0.87 earnings per share. Equities analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on CL shares. Raymond James reaffirmed an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Barclays dropped their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. Wells Fargo & Company cut their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.